Related Experiment Videos
The role of C-reactive protein in cardiovascular disease risk
1Cardiovascular Division, Brigham and Women's Hospital, Harvard University Medical School, 75 Francis Street, Boston, MA 02115, USA.
Insights
Inflammation, indicated by C-reactive protein (CRP), is linked to coronary artery disease risk. CRP may serve as a marker for atherosclerosis and predict cardiovascular events, potentially influencing treatment efficacy.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- Atherosclerotic plaque formation involves immune cells, lipids, and endothelial cells.
- Inflammation is implicated in the progression of coronary artery disease (CAD).
- C-reactive protein (CRP) is an acute inflammatory peptide associated with cardiovascular risk.
Purpose of the Study:
- To explore the role of inflammation, specifically CRP, in cardiovascular disease.
- To evaluate CRP as a potential marker for sub-clinical atherosclerosis and future cardiovascular events.
- To investigate the relationship between CRP levels and the efficacy of secondary preventive therapies.
Main Methods:
- Review of existing scientific literature linking inflammation markers to cardiovascular outcomes.
- Analysis of studies correlating C-reactive protein (CRP) levels with coronary artery disease risk factors and events.
- Examination of preliminary data on CRP's influence on the effectiveness of statins and aspirin.
Main Results:
- CRP is independently associated with future coronary events across diverse populations (healthy individuals, elderly, high-risk patients).
- Elevated CRP levels correlate with peripheral vascular disease and stroke.
- Emerging evidence suggests CRP levels may modulate the effectiveness of secondary preventive treatments like statins and aspirin.
Conclusions:
- Inflammation, as indicated by CRP, plays a significant role in coronary artery disease pathogenesis and risk prediction.
- C-reactive protein (CRP) is a valuable biomarker for assessing sub-clinical atherosclerosis and future cardiovascular risk.
- Individual CRP levels may guide therapeutic decisions for secondary prevention in cardiovascular disease.
Abstract:
The genesis of an atherosclerotic plaque depends on interplay of cellular components of the immune system such as monocytes, cytokines, and cell adhesion molecules with lipids, platelets and endothelial cells. Thus, inflammation may play a pivotal role in the propagation of coronary artery disease. Several reports have linked inflammation and cardiovascular risk, particularly a novel acute inflammatory peptide, C-reactive protein (CRP), with future risk of coronary events independent of the traditional coronary artery disease risk factors. To this end, many studies suggest that CRP may be used as a marker of sub-clinical atherosclerosis and cardiovascular risk. Specifically, CRP has been positively linked to future cardiovascular events in healthy women, healthy men, elderly patients, and high-risk individuals. In addition, reports have shown associations between CRP and peripheral vascular disease and stroke. Furthermore, preliminary data suggest that the relative efficacy of secondary preventive therapies such as statin drugs and aspirin may depend on the individual patient's baseline CRP level.